|
9 |
6-minute walking distance (6-MWD) |
isolated CHD: CHD with PAH |
protective factor |
|
10 |
NT‐proBNP |
isolated CHD: CHD with PAH |
protective factor |
|
21 |
depression score (≥3) |
isolated CHD/non-isolated CHD: TAPVR/ASD/VSD/AVSD/CoA/TGA/ccTGA/CACA/DORV, DILV/EA/PDA/PVD/TA/TOF/other |
protective factor |
|
22 |
delayed sleep onset |
isolated CHD/non-isolated CHD: TAPVR/ASD/VSD/AVSD/CoA/TGA/ccTGA/CACA/DORV, DILV/EA/PDA/PVD/TA/TOF/other |
protective factor |
|
23 |
nocturnal awakenings |
isolated CHD/non-isolated CHD: TAPVR/ASD/VSD/AVSD/CoA/TGA/ccTGA/CACA/DORV, DILV/EA/PDA/PVD/TA/TOF/other |
protective factor |
|
37 |
Cord blood BNP |
NA: NA |
protective factor |
|
39 |
Cord blood BNP |
NA: NA |
protective factor |
|
67 |
outcome of ischemic placental disease |
isolated CHD: Anomalies of venous return |
protective factor |
|
68 |
outcome of ischemic placental disease |
non-isolated CHD: Anomalies of the atria and interatrial communications |
protective factor |
|
69 |
outcome of ischemic placental disease |
non-isolated CHD: Anomalies of atrioventricular junctions and valves |
protective factor |
|
92 |
gestational age at delivery with cardiac complication |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/ASD, VSD/ASD, PDA/VSD, PDA/VSD, ES/PDA, ES/VSD, CHD with PAH |
protective factor |
|
95 |
lower SaO2 |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/ASD, VSD/ASD, PDA/VSD, PDA/VSD, ES/PDA, ES/VSD, CHD with PAH |
protective factor |
|
159 |
higher maternal total fat intake |
isolated CHD/non-isolated CHD: DIVM/DIVM, other |
protective factor |
|
221 |
seraphin(duration of drug administration) |
isolated CHD: ASD/VSD/PTA |
protective factor |
|
225 |
6-MWD |
isolated CHD: CHD with PAH |
protective factor |
|
337 |
5-year mortality |
isolated CHD/non-isolated CHD: VSD/VSD, PDA/CoA/CAVC/DORV |
protective factor |
|
358 |
executive dysfunction-direct effect on QOL |
isolated CHD/non-isolated CHD: D-TGA, IVS/D-TGA, VSD/TOF/TOF, PS/TA/VSD/TA, IAA/VSD, CoA/CoA, AH/PS, IVS/SV/HLHS/SV, AO |
protective factor |
|
359 |
Aortic obstruction-indirect effect on QOL |
isolated CHD/non-isolated CHD: D-TGA, IVS/D-TGA, VSD/TOF/TOF, PS/TA/VSD/TA, IAA/VSD, CoA/CoA, AH/PS, IVS/SV/HLHS/SV, AO |
protective factor |
|
360 |
premature birth-indirect effect on QOL |
isolated CHD/non-isolated CHD: D-TGA, IVS/D-TGA, VSD/TOF/TOF, PS/TA/VSD/TA, IAA/VSD, CoA/CoA, AH/PS, IVS/SV/HLHS/SV, AO |
protective factor |
|
361 |
male sex-indirect effect on QOL |
isolated CHD/non-isolated CHD: D-TGA, IVS/D-TGA, VSD/TOF/TOF, PS/TA/VSD/TA, IAA/VSD, CoA/CoA, AH/PS, IVS/SV/HLHS/SV, AO |
protective factor |
|
368 |
Low physical HRQoL-Educational level |
isolated CHD/non-isolated CHD: BAV/RVSD/MVD/PVS/AVD/ASD/VSD/SVD/PDA/CoA/EA/PS/AVSD/SVAS/HCM/TOF/DORV/RVD/Shone's Complex/PA/ccTGA/TGA/ES/C-CHD/other |
protective factor |
|
369 |
Low physical HRQoL-Maximum physical capacity |
isolated CHD/non-isolated CHD: BAV/RVSD/MVD/PVS/AVD/ASD/VSD/SVD/PDA/CoA/EA/PS/AVSD/SVAS/HCM/TOF/DORV/RVD/Shone's Complex/PA/ccTGA/TGA/ES/C-CHD/other |
protective factor |
|
370 |
Low mental HRQoL-social support |
isolated CHD/non-isolated CHD: BAV/RVSD/MVD/PVS/AVD/ASD/VSD/SVD/PDA/CoA/EA/PS/AVSD/SVAS/HCM/TOF/DORV/RVD/Shone's Complex/PA/ccTGA/TGA/ES/C-CHD/other |
protective factor |
|
371 |
Impaired poor psychological adjustment-social support |
isolated CHD/non-isolated CHD: BAV/RVSD/MVD/PVS/AVD/ASD/VSD/SVD/PDA/CoA/EA/PS/AVSD/SVAS/HCM/TOF/DORV/RVD/Shone's Complex/PA/ccTGA/TGA/ES/C-CHD/other |
protective factor |
|
422 |
the mutant allete C of 5, 10 methylenetetrahydrofolate reductase (MTHFR) A1298C C |
isolated CHD: ASD/VSD/PDA/TOF/PVS |
protective factor |
|
423 |
the mutant allete AC of 5,10 methylenetetrahydrofolate reductase (MTHFR) A1298C AC |
isolated CHD: ASD/VSD/PDA/TOF/PVS |
protective factor |
|
506 |
2 year cognitive composite score |
isolated CHD/non-isolated CHD: SV/HLHS/Taussig–Bing anomaly/IAA, HAA/CoA, HAA |
protective factor |
|
507 |
6 year full-scale IQ |
isolated CHD/non-isolated CHD: SV/HLHS/Taussig–Bing anomaly/IAA, HAA/CoA, HAA |
protective factor |
|
510 |
basal ganglia and thalamus(BGT) |
isolated CHD/non-isolated CHD: SV/HLHS/Taussig–Bing anomaly/IAA, HAA/CoA, HAA |
protective factor |
|
511 |
brain stem(BS) |
isolated CHD/non-isolated CHD: SV/HLHS/Taussig–Bing anomaly/IAA, HAA/CoA, HAA |
protective factor |
|
543 |
apoferritn levels ng/mL |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/PS/AOS/Bc/CoA/D-TGA/ccTGA/TOF/EA/other |
protective factor |
|
548 |
Urban accessibility |
isolated CHD: PDA/ASD/VSD |
protective factor |
|
549 |
LST (Land surface temperature) |
isolated CHD: PDA/ASD/VSD |
protective factor |
|
550 |
Real GDP (Gross domestic product) |
isolated CHD: PDA/ASD/VSD |
protective factor |
|
686 |
Lowset temperature |
isolated CHD/non-isolated CHD: NA |
protective factor |
|
719 |
Pulmonary artery resistance(PAR) |
isolated CHD: CHD with PAH/EA |
protective factor |
|
791 |
Age |
isolated CHD/non-isolated CHD: AV/ASD/VSD/PDA/ASD, VSD, repaired ductus arteriosus/AVSD, ASD/CoA/DORV/PA/TGA/ccTGA/UVA/ES/TOF/EA/other |
protective factor |
|
793 |
age |
isolated CHD/non-isolated CHD: NA |
protective factor |
|
798 |
forced vital capacity(FVC) |
isolated CHD/non-isolated CHD: NA |
protective factor |
|
800 |
independent predictors of a restrictive lung pattern(body mass index, BMI) |
isolated CHD/non-isolated CHD: NA |
protective factor |
|
807 |
independent predictors of an impaired exercise capacity(BMI) |
isolated CHD/non-isolated CHD: NA |
protective factor |
|
808 |
independent predictors of an impaired exercise capacity(sex female) |
isolated CHD/non-isolated CHD: NA |
protective factor |
|
810 |
independent predictors of an impaired exercise capacity: FVC (%predicted) |
isolated CHD/non-isolated CHD: NA |
protective factor |
|
814 |
Predictors of survival in logistic regression model for all 1281 patients with valid cardiopulmonary exercise test(age) |
isolated CHD/non-isolated CHD: NA |
protective factor |
|
815 |
Predictors of survival in logistic regression model for all 1281 patients with valid cardiopulmonary exercise test(thoracotomies) |
isolated CHD/non-isolated CHD: NA |
protective factor |
|
920 |
FIGN +94762G>C(Genotype: GC) (rs2119289)--Shanghai group |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
protective factor |
|
921 |
FIGN +94762G>C(Genotype: CC) (rs2119289)--Shanghai group |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
protective factor |
|
923 |
FIGN +94762G>C(allele: C) (rs2119289)--Shanghai group |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
protective factor |
|
925 |
FIGN +94762G>C(Genotype: GC) (rs2119289)--Shandong group |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
protective factor |
|
926 |
FIGN +94762G>C(Genotype: CC) (rs2119289)--Shandong group |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
protective factor |
|
928 |
FIGN +94762G>C(allele: C) (rs2119289)--Shandong group |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
protective factor |
|
930 |
FIGN +94762G>C(Genotype: GC) (rs2119289)--Anhui group |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
protective factor |
|
931 |
FIGN +94762G>C(Genotype: CC) (rs2119289)--Anhui group |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
protective factor |
|
933 |
FIGN +94762G>C(allele: C) (rs2119289)--Anhui group |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
protective factor |
|
935 |
FIGN +94762G>C(Genotype: GC) (rs2119289)--Combined |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
protective factor |
|
936 |
FIGN +94762G>C(Genotype: CC) (rs2119289)--Combined |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
protective factor |
|
938 |
FIGN +94762G>C(allele: C) (rs2119289)--Combined |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
protective factor |
|
966 |
GIT symptoms--Diarrhea (Negative, percent) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
protective factor |
|
967 |
GIT symptoms--Abdominal pain (Positive, percent) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
protective factor |
|
968 |
GIT symptoms--Abdominal distension (Positive, percent) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
protective factor |
|
970 |
GIT symptoms--Diarrhea (Negative, percent) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
protective factor |
|
971 |
GIT symptoms--Abdominal pain (Positive, percent) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
protective factor |
|
972 |
GIT symptoms--Abdominal distension (Positive, percent) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
protective factor |
|
974 |
GIT symptoms--Abdominal pain (Positive, percent) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
protective factor |
|
975 |
GIT symptoms--Abdominal distension (Positive, percent) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
protective factor |
|
1012 |
Impaired mental HrQoL(minimally active) |
isolated CHD: TOF/PS/AS/CoA/TGA/EA/ASD/VSD/AVSD |
protective factor |
|
1013 |
Impaired mental health-related quality of life(HrQoL) |
isolated CHD: TOF/PS/AS/CoA/TGA/EA/ASD/VSD/AVSD |
protective factor |
|
1014 |
Impaired physical -HrQoL |
isolated CHD: TOF/PS/AS/CoA/TGA/EA/ASD/VSD/AVSD |
protective factor |
|
1015 |
Impaired exercise capacity |
isolated CHD: TOF/PS/AS/CoA/TGA/EA/ASD/VSD/AVSD |
protective factor |
|
1016 |
Impaired exercise capacity |
isolated CHD: TOF/PS/AS/CoA/TGA/EA/ASD/VSD/AVSD |
protective factor |
|
1039 |
Predictors of procedural failure--Class III agents |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
protective factor |
|
1049 |
ABO blood group--isolated CHD |
isolated CHD: VSD/ASD/TOF/DORV/CoA/PDA/PA/TGA |
protective factor |
|
1050 |
gender (Male vs Female)--isolated CHD |
isolated CHD: VSD/ASD/TOF/DORV/CoA/PDA/PA/TGA |
protective factor |
|
1051 |
ABO blood group--VSD |
isolated CHD: VSD/ASD/TOF/DORV/CoA/PDA/PA/TGA |
protective factor |
|
1052 |
ABO blood group--ASD |
isolated CHD: VSD/ASD/TOF/DORV/CoA/PDA/PA/TGA |
protective factor |
|
1053 |
ABO blood group--PDA |
isolated CHD: VSD/ASD/TOF/DORV/CoA/PDA/PA/TGA |
protective factor |
|
1054 |
ABO blood group--TOF |
isolated CHD: VSD/ASD/TOF/DORV/CoA/PDA/PA/TGA |
protective factor |
|
1055 |
ABO blood group--PA |
isolated CHD: VSD/ASD/TOF/DORV/CoA/PDA/PA/TGA |
protective factor |
|
1056 |
ABO blood group--DORV |
isolated CHD: VSD/ASD/TOF/DORV/CoA/PDA/PA/TGA |
protective factor |
|
1057 |
ABO blood group--TGA |
isolated CHD: VSD/ASD/TOF/DORV/CoA/PDA/PA/TGA |
protective factor |
|
1058 |
ABO blood group--COA |
isolated CHD: VSD/ASD/TOF/DORV/CoA/PDA/PA/TGA |
protective factor |
|
1100 |
Age, months |
isolated CHD/non-isolated CHD: TOF/AVC/CoA/IAA/PA/TGA/VSD, ASD/CAT/HLHS/TAPVC/AR/other |
protective factor |
|
1165 |
VIS |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
protective factor |
|
1166 |
Delayed sternal closure--≥72 hr |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
protective factor |
|
1167 |
Reintubation--≥72 hr |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
protective factor |
|
1170 |
Weight--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
protective factor |
|
1172 |
VIS--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
protective factor |
|
1173 |
Delayed sternal closure--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
protective factor |
|
1175 |
Respiratory complications--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
protective factor |
|
1258 |
African American–white disparity in neonatal mortality rate due to CHD |
NA: LSOOL/CTDs/RSOOL/SD/AVSD/Lesions of veins/Lesions of arteries |
protective factor |
|
1343 |
Mortality |
isolated CHD: D-TGA/VSD/CHD with PAH |
protective factor |
|
1344 |
Morbidity |
isolated CHD: D-TGA/VSD/CHD with PAH |
protective factor |
|
1348 |
The mWHO risk classification |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/PDA/MVS/MP/BAV/AS/PS/DPA/TS/TOF/EA/NA/TGA/TAPVD |
protective factor |
|
1349 |
ZAHARA score |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/PDA/MVS/MP/BAV/AS/PS/DPA/TS/TOF/EA/NA/TGA/TAPVD |
protective factor |
|
1350 |
CARPREG score |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/PDA/MVS/MP/BAV/AS/PS/DPA/TS/TOF/EA/NA/TGA/TAPVD |
protective factor |
|
1460 |
Age |
isolated CHD/non-isolated CHD: C-CHD/non C-CHD |
protective factor |
|
1461 |
Weight |
isolated CHD/non-isolated CHD: C-CHD/non C-CHD |
protective factor |
|
1462 |
Hospital stay duration |
isolated CHD/non-isolated CHD: C-CHD/non C-CHD |
protective factor |
|
1463 |
cyanotic congenital cardiac disease |
isolated CHD/non-isolated CHD: C-CHD/non C-CHD |
protective factor |
|
1493 |
serum insulin |
isolated CHD: D-TGA |
protective factor |
|
1503 |
cyanotic ACHD |
isolated CHD/non-isolated CHD: ASD/TOF/VSD/DORV/PDA/EA/AVSD/L-TGA/SV/PA, VSD, MAPCA/TA/PS/TAS/D-TGA |
protective factor |
|
1524 |
GDF-15 |
isolated CHD/non-isolated CHD: AS/AC/TOF/TGA/ccTGA/NA/PAH/TGA, VSD, DORV |
protective factor |
|
1548 |
P-selectin candidate gene SNPs---827T/C:CT |
isolated CHD: ASD/PDA/VSD |
protective factor |
|
1549 |
P-selectin candidate gene SNPs---827T/C:CT+CC |
isolated CHD: ASD/PDA/VSD |
protective factor |
|
1551 |
P-selectin candidate gene SNPs---827T/C:CT |
isolated CHD: ASD/PDA/VSD |
protective factor |
|
1552 |
P-selectin candidate gene SNPs---827T/C:CT+CC |
isolated CHD: ASD/PDA/VSD |
protective factor |
|
1724 |
Correlation: NLR (neutrophil to lymphocyte ratio)--PPAP |
isolated CHD/non-isolated CHD: VSD/p-AVSD/VSD, PDA/VSD, SAS/DORV/TAPVC/CAVSD/TA/MS, VSD |
protective factor |
|
1725 |
Correlation: CRP (C-reactive protein)--PPAP(mean pulmonary artery pressure) |
isolated CHD/non-isolated CHD: VSD/p-AVSD/VSD, PDA/VSD, SAS/DORV/TAPVC/CAVSD/TA/MS, VSD |
protective factor |
|
1726 |
Correlation: Patient age--PPAP |
isolated CHD/non-isolated CHD: VSD/p-AVSD/VSD, PDA/VSD, SAS/DORV/TAPVC/CAVSD/TA/MS, VSD |
protective factor |
|
1727 |
Correlation: NLR (neutrophil to lymphocyte ratio)--mPAP |
isolated CHD/non-isolated CHD: VSD/p-AVSD/VSD, PDA/VSD, SAS/DORV/TAPVC/CAVSD/TA/MS, VSD |
protective factor |
|
1728 |
Correlation: CRP (C-reactive protein)--mPAP |
isolated CHD/non-isolated CHD: VSD/p-AVSD/VSD, PDA/VSD, SAS/DORV/TAPVC/CAVSD/TA/MS, VSD |
protective factor |
|
1729 |
Correlation: Patient age--mPAP |
isolated CHD/non-isolated CHD: VSD/p-AVSD/VSD, PDA/VSD, SAS/DORV/TAPVC/CAVSD/TA/MS, VSD |
protective factor |
|
1748 |
incidence of TA, tachyarrhythmia |
NA: NA |
protective factor |
|
1749 |
incidence of TA receiving intervention |
NA: NA |
protective factor |
|
1750 |
incidence of BA,bradyarrhythmia |
NA: NA |
protective factor |
|
1751 |
incidence of BA receiving intervention |
NA: NA |
protective factor |
|
1752 |
incidence of JET,junctional ectopic tachycardia |
NA: NA |
protective factor |
|
1753 |
incidence of JET receiving intervention |
NA: NA |
protective factor |
|
1824 |
serum Cys C levels |
NA: NA |
protective factor |
|
1836 |
younger age groups at the time of surgery |
isolated CHD/non-isolated CHD: HOCM, SAS, DCRV/VSD/D-TGA, VSD, PS, TVD/MS/DORV, TGA, VSD/ccTGA, PA, VSD/AVSD/AA, VSD, ASD, CoA |
protective factor |
|
1868 |
calcium supplement during early pregnancy |
isolated CHD: ASD/VSD/other |
protective factor |
|
1871 |
systemic atery systolic blood pressure(SBP) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/NA |
protective factor |
|
1893 |
Year of catheterization |
isolated CHD: PDA/ASD/PV/PAS/TGA/CoA/PFO/AVS/PA/TOF/DORV/UVH/VSD/other |
protective factor |
|
1916 |
WHO class |
isolated CHD: ASD/VSD/AVSD/APVR/PS/AVS/BAV/AC/EA/TOF/TGA/other |
protective factor |
|
1917 |
ZAHARA I risk score |
isolated CHD: ASD/VSD/AVSD/APVR/PS/AVS/BAV/AC/EA/TOF/TGA/other |
protective factor |
|
1918 |
Composite ROC [optimal combination of risk assessment models (WHO class, total no. cardiovascular predictors and disease complexity)]. |
isolated CHD: ASD/VSD/AVSD/APVR/PS/AVS/BAV/AC/EA/TOF/TGA/other |
protective factor |
|
1919 |
total no. cardiovascular predictors |
isolated CHD: ASD/VSD/AVSD/APVR/PS/AVS/BAV/AC/EA/TOF/TGA/other |
protective factor |
|
1920 |
disease complexity |
isolated CHD: ASD/VSD/AVSD/APVR/PS/AVS/BAV/AC/EA/TOF/TGA/other |
protective factor |
|
1921 |
the total number of cardiovascular (TPc) or offspring risk predictors (TPo) |
isolated CHD: ASD/VSD/AVSD/APVR/PS/AVS/BAV/AC/EA/TOF/TGA/other |
protective factor |
|
1949 |
predictor of unscheduled hospitalization: Peak VO2(per 1.0ml/kg/min) |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
protective factor |
|
1951 |
predictor of unscheduled hospitalization: Atrerial oxygen saturation |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
protective factor |
|
1964 |
predictor of mortality: Peak VO2(per 1.0ml/kg/min) |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
protective factor(univariate model) |
|
1965 |
predictor of mortality: Atrerial oxygen saturation |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
protective factor(univariate model) |
|
2031 |
Hcy(predict dynamic and obstructive PH) |
isolated CHD: VSD/ASD/PDA/PAH/ES |
protective factor |
|
2032 |
H2S( predict dynamic and obstructive PH) |
isolated CHD: VSD/ASD/PDA/PAH/ES |
protective factor |
|
2033 |
CSE expression(predict dynamic and obstructive PH) |
isolated CHD: VSD/ASD/PDA/PAH/ES |
protective factor |
|
2109 |
physical exercise>3h/week |
isolated CHD: AVD |
protective factor |
|
2340 |
GGC repeat ≥13 |
NA: CHD with PAH |
protective factor |
|
2368 |
Correlation between exercise time and maternal events |
isolated CHD/non-isolated CHD: ASD/VSD/AVS/PVS/CoA/TOF/TOF, PA/ccTGA/TGA/EA/DORV/TAPVC/PA, IVS/TGA/TA |
protective factor |
|
2369 |
Correlation between peak HR and maternal events |
isolated CHD/non-isolated CHD: ASD/VSD/AVS/PVS/CoA/TOF/TOF, PA/ccTGA/TGA/EA/DORV/TAPVC/PA, IVS/TGA/TA |
protective factor |
|
2370 |
Correlation between peak SBP (systolic blood pressure) and maternal events |
isolated CHD/non-isolated CHD: ASD/VSD/AVS/PVS/CoA/TOF/TOF, PA/ccTGA/TGA/EA/DORV/TAPVC/PA, IVS/TGA/TA |
protective factor |
|
2371 |
Correlation between peak oxygen uptake and maternal events |
isolated CHD/non-isolated CHD: ASD/VSD/AVS/PVS/CoA/TOF/TOF, PA/ccTGA/TGA/EA/DORV/TAPVC/PA, IVS/TGA/TA |
protective factor |
|
2372 |
Correlation between exercise time and neonatal events |
isolated CHD/non-isolated CHD: ASD/VSD/AVS/PVS/CoA/TOF/TOF, PA/ccTGA/TGA/EA/DORV/TAPVC/PA, IVS/TGA/TA |
protective factor |
|
2373 |
Correlation between anaerobic threshold (Oxygen uptake) and neonatal events |
isolated CHD/non-isolated CHD: ASD/VSD/AVS/PVS/CoA/TOF/TOF, PA/ccTGA/TGA/EA/DORV/TAPVC/PA, IVS/TGA/TA |
protective factor |
|
2374 |
Correlation between peak Oxygen uptake and neonatal events |
isolated CHD/non-isolated CHD: ASD/VSD/AVS/PVS/CoA/TOF/TOF, PA/ccTGA/TGA/EA/DORV/TAPVC/PA, IVS/TGA/TA |
protective factor |
|
2449 |
Relative importance of individual symptom to perceived health：male |
isolated CHD/non-isolated CHD: VSD, ASD, ASDI, PDA/TOF, PS/BAV, AS, SVAS/CoA/TGA/other |
protective factor |
|
2450 |
Relative importance of individual symptom to perceived health：age |
isolated CHD/non-isolated CHD: VSD, ASD, ASDI, PDA/TOF, PS/BAV, AS, SVAS/CoA/TGA/other |
protective factor |
|
2451 |
Relative importance of individual symptom to perceived health：NYHA-II |
isolated CHD/non-isolated CHD: VSD, ASD, ASDI, PDA/TOF, PS/BAV, AS, SVAS/CoA/TGA/other |
protective factor |
|
2452 |
Relative importance of individual symptom to perceived health：NYHA-III |
isolated CHD/non-isolated CHD: VSD, ASD, ASDI, PDA/TOF, PS/BAV, AS, SVAS/CoA/TGA/other |
protective factor |
|
2453 |
Relative importance of individual symptom to perceived health：NYHA-IV |
isolated CHD/non-isolated CHD: VSD, ASD, ASDI, PDA/TOF, PS/BAV, AS, SVAS/CoA/TGA/other |
protective factor |
|
2454 |
Relative importance of individual symptom to perceived health：Shortness of breath walking 1-5 km |
isolated CHD/non-isolated CHD: VSD, ASD, ASDI, PDA/TOF, PS/BAV, AS, SVAS/CoA/TGA/other |
protective factor |
|
2455 |
Relative importance of individual symptom to perceived health：Orthopnea |
isolated CHD/non-isolated CHD: VSD, ASD, ASDI, PDA/TOF, PS/BAV, AS, SVAS/CoA/TGA/other |
protective factor |
|
2456 |
Relative importance of individual symptom to perceived health：Nycturia |
isolated CHD/non-isolated CHD: VSD, ASD, ASDI, PDA/TOF, PS/BAV, AS, SVAS/CoA/TGA/other |
protective factor |
|
2457 |
Relative importance of individual symptom to perceived health：Palpitations |
isolated CHD/non-isolated CHD: VSD, ASD, ASDI, PDA/TOF, PS/BAV, AS, SVAS/CoA/TGA/other |
protective factor |
|
2458 |
Relative importance of individual symptom to perceived health：Dizziness |
isolated CHD/non-isolated CHD: VSD, ASD, ASDI, PDA/TOF, PS/BAV, AS, SVAS/CoA/TGA/other |
protective factor |
|
2460 |
Relationship between symptom distress and perceived health |
NA: NA |
protective factor |
|
2461 |
Factor related the surgical success rate for PDA: PDA size |
isolated CHD: PDA |
protective factor |
|
2462 |
Factor related the surgical success rate for PDA: procedure time |
isolated CHD: PDA |
protective factor |
|
2465 |
Factor related the surgical success rate and complications for ASD: ASD maximal size |
isolated CHD: ASD |
protective factor |
|
2466 |
Factor related the surgical success rate and complications for ASD: procedure time |
isolated CHD: ASD |
protective factor |
|
2472 |
Risk factor related the occurrence of complications for PBPV: Body weight |
isolated CHD: PS |
protective factor |
|
2511 |
BMI (>25) |
NA: NA |
protective factor |
|
2512 |
BMI (21-25) (reference=BMI<21) |
NA: NA |
protective factor |
|
2642 |
age (months) |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
protective factor |
|
2644 |
Weight (kg) |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
protective factor |
|
2724 |
Age at implantation (years) |
isolated CHD: LVOTO/ASD/VSD/AVSD/TGA/TOF/other |
protective factor |
|
2740 |
logistic regression analysis and risk of mortality: Weight (kg)(neonates≤30 days) |
isolated CHD: PA/VSD/ASD/TA/AVSD/TAPVC/other |
protective factor |
|
2752 |
Age (y)(risk factors associated with redo PVR) |
isolated CHD/non-isolated CHD: TOF/PA, VSD/DORV/TGA/PS/other |
protective factor |
|
2874 |
CPB time (min) |
isolated CHD/non-isolated CHD: AS, VSD/TCPC/PA, VSD/AVSD/PA, EA/DORV, VSD/PA, IVS/TAPVD/other |
protective factor |
|
2894 |
lowest SaO2(arterial oxygen saturation) |
isolated CHD: TGA/SV |
protective factor |
|
2975 |
preoperative NYHA class I |
isolated CHD/non-isolated CHD: ASD/VSD/PAPVC/p-AVSD/TGA, IVS/EA/CoA/VPS/SAS/SPS/AI/other |
protective factor |
|
2976 |
surgery for 'septal defect'(ASDs,VSDs,AVSDs) |
isolated CHD/non-isolated CHD: ASD/VSD/PAPVC/p-AVSD/TGA, IVS/EA/CoA/VPS/SAS/SPS/AI/other |
protective factor |
|
3110 |
correlation between younger maternal age (per year) and obstetric complications |
isolated CHD/non-isolated CHD: ASD/VSD/AVC/PS/PA, RV to PAC/DCRV, VSD/AS/AC/TOF/D-TGA, VSD, PS/ccTGA/SV/EA |
protective factor |
|
3113 |
correlation between oxygen saturation and obstetric complications |
isolated CHD/non-isolated CHD: ASD/VSD/AVC/PS/PA, RV to PAC/DCRV, VSD/AS/AC/TOF/D-TGA, VSD, PS/ccTGA/SV/EA |
protective factor |
|
3140 |
Mother's education level |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
protective factor |
|
3244 |
weight (per kilo) |
isolated CHD/non-isolated CHD: HLHS/VSD, PS/UVH, PS/PATR, TOF/UVH/CAT/CAT, IAA/VSD, ASDII/AVSD/VSD, ASD/TGA, AVSD, IAA/AVSD/IAA, VSD, ASD/HLHS/AVSD/TGA, PATR, VSD/TGA/VSD/AVSD/TAPVD/DORV/other |
protective factor |
|
3264 |
surgical intervention |
isolated CHD/non-isolated CHD: VSD/VSD, ASD/VSD, PDA/MS/AS/CoA, VSD/CoA/ccTGA/EA/DORV/TOF/ccTGA/ASD/CAT/ccTGA, VSD, PS/TS, HRV, PS/AVAS/other |
protective factor |
|
3265 |
age < 0.1 year |
NA: NA |
protective factor |
|
3268 |
calender year 1997-99 |
NA: NA |
protective factor |
|
3269 |
calender year 2000-02 |
NA: NA |
protective factor |
|
3344 |
Aristotle<14 |
isolated CHD/non-isolated CHD: SV/HLHS/PA, IVS/AVC/CAT/TOF/DORV/TAPVC/IAA, VSD/PA, VSD |
protective factor |
|
3363 |
complication rates |
isolated CHD/non-isolated CHD: PA/MAPCA/arterial duct/Systemic vein/RVOTO, pulmonary trunk/APS/PV/CACA/other |
protective factor |
|
3380 |
Heart rate reserve (10 beats/min) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
protective factor |
|
3381 |
Chronotropic index |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
protective factor |
|
3382 |
Peak heart rate (10 beats/min) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
protective factor |
|
3383 |
percentage predicted peak heart rate |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
protective factor |
|
3384 |
heart rate recovery 1 minute (beats/min) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
protective factor |
|
3385 |
heart rate recovery 2 minute (beats/min) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
protective factor |
|
3386 |
heart rate recovery 3 minute (beats/min) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
protective factor |
|
3387 |
heart rate recovery 5 minute (beats/min) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
protective factor |
|
3388 |
Peak VO2 (ml/kg/min) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
protective factor |
|
3394 |
Heart rate reserve (10 beats/min) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
protective factor |
|
3397 |
Heart rate reserve (10 beats/min) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
protective factor |
|
3410 |
Parents' highest education high school graduate or less |
NA: NA |
protective factor |
|
3438 |
Peak VO2 |
isolated CHD/non-isolated CHD: ASD/AVSD/ccTGA/CoA/other/EA/ES/TOF/CHD with PAH/VSD |
protective factor |
|
3439 |
peak heart rate |
isolated CHD/non-isolated CHD: ASD/AVSD/ccTGA/CoA/other/EA/ES/TOF/CHD with PAH/VSD |
protective factor |
|
3527 |
CHD recognition route C versus A (outcome 2 measured by death) |
isolated CHD/non-isolated CHD: LHO/TGA/PA/SV/TAPVC/other |
protective factor |
|
3940 |
association with age and recrational drug use |
NA: NA |
protective factor |
|
3941 |
association with sex and recrational drug use |
NA: NA |
protective factor |
|
3945 |
association between sports participation with age |
NA: NA |
protective factor |
|
3946 |
association with sports participation with defect complexity |
NA: NA |
protective factor |
|
3947 |
association with sports participation with sex |
NA: NA |
protective factor |
|
3951 |
association with sports participation with cardiac defect functional status |
NA: NA |
protective factor |
|
3952 |
white |
isolated CHD: SV dd-SBF/BiV dd-SBF/D-TGA/BiV dd-PBF/SV dd-PBF/SV/TA/other |
protective factor |
|
3955 |
exclusively unfortified HMD(human milk diet) |
isolated CHD: SV dd-SBF/BiV dd-SBF/D-TGA/BiV dd-PBF/SV dd-PBF/SV/TA/other |
protective factor |
|
3970 |
low T1(baseline) PHC(perveived health competence) |
NA: NA |
protective factor |
|
3971 |
low T1(baseline) PHC(perveived health competence) |
NA: NA |
protective factor |
|
4076 |
age(days)(infants) |
NA: NA |
protective factor |
|
4080 |
BMI(5th~95th percentile)(infants) |
NA: NA |
protective factor |
|
4084 |
Lymphocyte count(>cut off value)(infants) |
NA: NA |
protective factor |
|
4087 |
Lymphocytes/WBC(>cut off value)(infants) |
NA: NA |
protective factor |
|
4088 |
Neutrophils/WBC(
|
NA: NA |
protective factor |
|
|
4098 |
Lymphocyte count(>cut off value)(children) |
NA: NA |
protective factor |
|
4100 |
Lymphocytes/WBC(>cut off value)(children) |
NA: NA |
protective factor |
|
4119 |
Food types eaten 3 or more times per week(Oranges, strawberries, raspberries, pineapple, kiwi, cantaloupe, lemons, limes) |
isolated CHD/non-isolated CHD: anomalies of the venous return/ASD/AVSD, OPD/AVC/HLHS/VSD/TOF, TGA/CoA/CACA |
protective factor |
|
4128 |
age |
NA: NA |
protective factor |
|
4139 |
ventricular level shunt(left-to-right) |
NA: NA |
protective factor |
|
4143 |
pulmonary insufficiency(PI)(minimal) |
NA: NA |
protective factor |
|
4184 |
risk of preterm birth of different age(<25 years) |
isolated CHD: NA |
protective factor |
